KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 142 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $213,000 | -8.2% | 62,705 | +1.8% | 0.00% | 0.0% |
| Q2 2018 | $232,000 | -0.9% | 61,576 | +7.6% | 0.00% | 0.0% |
| Q1 2018 | $234,000 | -16.7% | 57,249 | -5.1% | 0.00% | 0.0% |
| Q4 2017 | $281,000 | -27.8% | 60,327 | +10.0% | 0.00% | 0.0% |
| Q3 2017 | $389,000 | +6.0% | 54,843 | +8.1% | 0.00% | 0.0% |
| Q2 2017 | $367,000 | +22.3% | 50,742 | +4.4% | 0.00% | 0.0% |
| Q1 2017 | $300,000 | +12.8% | 48,622 | +7.1% | 0.00% | 0.0% |
| Q4 2016 | $266,000 | -99.9% | 45,402 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $241,711,000 | -19.7% | 45,520 | +0.2% | 0.00% | 0.0% |
| Q2 2016 | $300,886,000 | -32.4% | 45,451 | -52.4% | 0.00% | -50.0% |
| Q1 2016 | $445,000,000 | -9.0% | 95,402 | -1.6% | 0.00% | 0.0% |
| Q4 2015 | $489,000,000 | +137259.6% | 96,946 | -4.2% | 0.00% | 0.0% |
| Q3 2015 | $356,000 | -100.0% | 101,194 | -0.3% | 0.00% | -50.0% |
| Q2 2015 | $1,013,389,000 | -23.7% | 101,542 | -2.6% | 0.00% | -20.0% |
| Q1 2015 | $1,327,446,000 | +9.4% | 104,277 | +21.6% | 0.01% | 0.0% |
| Q4 2014 | $1,213,745,000 | -2.9% | 85,777 | -5.6% | 0.01% | -16.7% |
| Q3 2014 | $1,249,518,000 | +6.5% | 90,874 | +19.1% | 0.01% | +20.0% |
| Q2 2014 | $1,173,248,000 | +11.0% | 76,284 | +23.0% | 0.01% | 0.0% |
| Q1 2014 | $1,056,923,000 | +38.5% | 62,026 | +5.3% | 0.01% | +25.0% |
| Q4 2013 | $763,169,000 | +19.6% | 58,932 | -6.7% | 0.00% | +33.3% |
| Q3 2013 | $637,994,000 | +31.9% | 63,176 | -2.4% | 0.00% | 0.0% |
| Q2 2013 | $483,758,000 | – | 64,760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |